Cohance Lifesciences share news, announcements and annual reports
NSE: COHANCEBSE: 543064Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 27 Oct 2026. Previous close ₹463.55.
27 Oct: open ₹463.00, high ₹483.70, low ₹460.55
- Next results date: the board meets on 6 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18,336 Cr428th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 172.61
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹21 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 143.70
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.69
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 3.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹21 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 4.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.04
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 12,27,88635.6% delivered
Cohance Lifesciences has 370 announcements on record, routine notices left out; 6 in the 30 days to 28 Oct 2026, the latest on 27 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Cohance Lifesciences quarterly results
The board meets on 6 Nov 2026 to consider financial results
Notice filed 26 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Cohance Lifesciences annual reports, presentations and earnings calls
The company's own documents, latest first.Cohance Lifesciences financials, year by year
Annual reports7
- Annual report, year to Mar 202626 Aug 2026
- Annual report, year to Mar 202526 Aug 2025
- Annual report, year to Mar 202416 Jul 2024
- Annual report, year to Mar 202322 Nov 2023, a zip file
- Annual report, year to Mar 202226 Jul 2022, a zip file
2 earlier reports
- Annual report, year to Mar 20216 Aug 2021, a zip file
- Annual report, year to Mar 202016 Sep 2020, a zip file
Investor presentations27
- Investor Presentation5 Aug 2026
- Investor Presentation12 May 2026
- Investor Presentation12 Feb 2026
- Investor Presentation12 Nov 2025
- Investor Presentation13 Aug 2025
22 earlier presentations
- Investor Presentation28 May 2025
- Investor Presentation12 Feb 2025
- Investor Presentation7 Dec 2024
- Investor Presentation12 Nov 2024
- Investor Presentation9 Aug 2024
- Investor Presentation13 Jun 2024
- Investor Presentation30 May 2024
- Investor Presentation29 Feb 2024
- Investor Presentation5 Feb 2024
- Investor Presentation24 Nov 2023
- Investor Presentation9 Nov 2023
- Investor Presentation8 Aug 2022
- Revised Investor Presentation9 May 2022
- Investor Presentation9 May 2022
- Investor Presentation8 Feb 2022
- Investor Presentation6 Nov 2021
- Investor Presentation16 Aug 2021
- Investor Presentation8 Jun 2021
- Investor Presentation11 Feb 2021
- Investor Presentation30 Oct 2020
- Investor Presentation17 Aug 2020
- Investor Presentation18 Jun 2020
Earnings calls48
- Transcript11 Aug 2026
- Link of Recording5 Aug 2026
- Transcript15 May 2026
- Link of Recording12 May 2026
- Transcript16 Feb 2026
43 earlier call documents
- Link of Recording12 Feb 2026
- Transcript17 Nov 2025
- Link of Recording12 Nov 2025
- Transcript1 Nov 2025
- Link of Recording28 Oct 2025
- Transcript19 Aug 2025
- Link of Recording13 Aug 2025
- Transcript2 Jun 2025
- Link of Recording28 May 2025
- Transcript18 Feb 2025
- Link of Recording12 Feb 2025
- Transcript13 Dec 2024
- Link of Recording9 Dec 2024
- Transcript17 Nov 2024
- Link of Recording12 Nov 2024
- Transcript14 Aug 2024
- Link of Recording9 Aug 2024
- Transcript21 Jun 2024
- Link of Recording19 Jun 2024
- Transcript4 Jun 2024
- Link of Recording31 May 2024
- Transcript11 Mar 2024
- Link of Recording6 Mar 2024
- Transcript9 Feb 2024
- Link of Recording6 Feb 2024
- Transcript14 Nov 2023
- Link of Recording10 Nov 2023
- Transcript14 Aug 2023
- Link of Recording11 Aug 2023
- Transcript2 Jun 2023
- Link of Recording26 May 2023
- Transcript13 Feb 2023
- Link of Recording7 Feb 2023
- Transcript30 Dec 2022
- Link of Recording27 Dec 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call15 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call10 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call16 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call9 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call8 Jun 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call2 Jun 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call13 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call11 May 2022
Cohance Lifesciences share news and announcements
Newest first. Page 1 of 8.
Oct 2026
27 Oct · Analysts
26 Oct · Board meeting
12 Oct
9 Oct · General Updates
6 Oct · General Updates
Sep 2026
21 Sep · Updates
18 Sep
17 Sep · Analysts
5 Sep · General Updates
3 Sep · Business
3 Sep · Committee Meeting Updates
Aug 2026
27 Aug · Analysts
26 Aug · General Updates
26 Aug · General Updates
26 Aug · Meeting
13 Aug · Rating
5 Aug · General Updates
5 Aug · Business
5 Aug · Results
Jul 2026
23 Jul · Analysts
23 Jul · Board meeting
Jun 2026
18 Jun · Management
2 Jun · Analysts
May 2026
25 May · Analysts
14 May · Meeting
13 May · Analysts
12 May · Results
6 May · Analysts
6 May · Board meeting
Apr 2026
30 Apr · Legal
The exchange asked on 29 Apr 2026
27 Apr · Management
27 Apr · General Updates
27 Apr · Business
27 Apr · Board meeting
12 Apr · Legal
The exchange asked on 10 Apr 2026
Mar 2026
6 Mar · Analysts
Feb 2026
20 Feb · Analysts
12 Feb · Results
6 Feb · General Updates
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 13 Aug 2026Credit ratingdown 0.03%0.0 pts vs Nifty 500market median 0.0% · five sessions +0.6% (+1.8 pts vs Nifty 500) · volume 0.6× usual · delivery −0.7 pts against usual · The announcement
- 6 Aug 2026Resultsup 2.20%+2.2 pts vs Nifty 500market median −0.7% · five sessions +3.5% (+3.7 pts vs Nifty 500) · volume 11.0× usual · delivery −26.6 pts against usual · The announcement
- 19 Jun 2026Board or managers changeddown 1.92%−1.7 pts vs Nifty 500market median 0.0% · five sessions +10.7% (+11.1 pts vs Nifty 500) · volume 1.1× usual · delivery +14.9 pts against usual · The announcement
- 18 Jun 2026Board or managers changeddown 2.67%−3.1 pts vs Nifty 500market median 0.0% · five sessions +8.7% (+8.7 pts vs Nifty 500) · volume 1.5× usual · delivery +3.6 pts against usual · The announcement
- 13 May 2026Resultsdown 5.85%−6.2 pts vs Nifty 500market median −0.7% · five sessions −11.6% (−12.6 pts vs Nifty 500) · volume 0.7× usual · delivery −7.9 pts against usual · The announcement
- 28 Apr 2026Board or managers changedup 14.16%+14.4 pts vs Nifty 500market median 0.0% · five sessions +5.1% (+5.2 pts vs Nifty 500) · volume 7.8× usual · delivery −19.0 pts against usual · The announcement
- 13 Feb 2026Resultsdown 10.02%−8.6 pts vs Nifty 500market median −0.7% · five sessions −10.2% (−8.7 pts vs Nifty 500) · volume 7.3× usual · delivery +3.9 pts against usual · The announcement
- 3 Feb 2026Board or managers changedup 2.68%0.0 pts vs Nifty 500market median 0.0% · five sessions −5.9% (−9.6 pts vs Nifty 500) · volume 0.4× usual · delivery −12.1 pts against usual · The announcement
- 8 Dec 2025Board or managers changeddown 2.28%−1.0 pts vs Nifty 500market median 0.0% · five sessions −1.2% (−0.8 pts vs Nifty 500) · volume 0.5× usual · delivery +10.1 pts against usual · The announcement
- 4 Dec 2025Credit ratingup 0.99%+0.9 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−1.5 pts vs Nifty 500) · volume 0.3× usual · delivery −0.2 pts against usual · The announcement
20 earlier announcements
- 28 Aug 2025Credit ratingdown 1.04%0.0 pts vs Nifty 500market median 0.0% · five sessions +2.7% (+2.3 pts vs Nifty 500) · volume 3.1× usual · delivery +27.5 pts against usual · The announcement
- 14 Aug 2025Resultsdown 7.32%−7.2 pts vs Nifty 500market median −0.7% · five sessions −8.9% (−10.9 pts vs Nifty 500) · volume 5.7× usual · delivery −7.5 pts against usual · The announcement
- 29 Jul 2025Board or managers changedup 1.62%+0.9 pts vs Nifty 500market median 0.0% · five sessions −3.7% (−3.8 pts vs Nifty 500) · volume 0.4× usual · delivery −10.6 pts against usual · The announcement
- 29 May 2025Resultsdown 3.81%−4.2 pts vs Nifty 500market median −0.7% · five sessions −7.8% (−8.0 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 29 May 2025Credit ratingdown 3.81%−4.2 pts vs Nifty 500market median 0.0% · five sessions −7.8% (−8.0 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 1 Apr 2025Board or managers changeddown 6.69%−5.4 pts vs Nifty 500market median 0.0% · five sessions −8.5% (−2.7 pts vs Nifty 500) · volume 1.6× usual · The announcement
- 3 Mar 2025Credit ratingdown 6.14%−6.2 pts vs Nifty 500market median 0.0% · five sessions −4.0% (−6.8 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 2 Dec 2024Credit ratingup 0.25%−0.4 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−3.1 pts vs Nifty 500) · volume 3.0× usual · The announcement
- 3 Oct 2024Board or managers changeddown 0.70%+1.4 pts vs Nifty 500market median 0.0% · five sessions +0.2% (+2.9 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 6 Sep 2024Credit ratingup 4.26%+5.5 pts vs Nifty 500market median 0.0% · five sessions +3.0% (+2.4 pts vs Nifty 500) · volume 3.9× usual · The announcement
- 12 Aug 2024Resultsup 4.69%+4.7 pts vs Nifty 500market median −0.7% · five sessions −0.7% (−1.6 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 12 Aug 2024Board or managers changedup 4.69%+4.7 pts vs Nifty 500market median 0.0% · five sessions −0.7% (−1.6 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 12 Mar 2024Credit ratingup 0.48%+1.1 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−2.9 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 26 Dec 2023Board or managers changeddown 0.34%−0.8 pts vs Nifty 500market median 0.0% · five sessions +1.2% (−1.0 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 1 Dec 2023Board or managers changedup 2.22%+1.5 pts vs Nifty 500market median 0.0% · five sessions +3.5% (−0.5 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 3 Oct 2023Board or managers changedup 2.24%+2.5 pts vs Nifty 500market median 0.0% · five sessions +0.8% (+1.8 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 17 Jan 2023Credit ratingup 0.03%−0.6 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−0.9 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 2 Sep 2022Dividenddown 0.17%−0.1 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−1.6 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 25 Apr 2022Credit ratingdown 0.25%+1.2 pts vs Nifty 500market median 0.0% · five sessions +5.2% (+5.9 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 8 Feb 2022Dividendup 1.91%+2.0 pts vs Nifty 500market median 0.0% · five sessions −11.1% (−7.9 pts vs Nifty 500) · volume 2.6× usual · The announcement
Cohance Lifesciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Dealing with a related party in the period | Quarter to Mar 2026 | Standalone | 15.62 | 15.67 | +0.3% | 12 May 2026 | 27 Jul 2026 |